Cargando…
Crosstalk between Cdk5 and GSK3β: Implications for Alzheimer's Disease
GSK3β and Cdk5 are the two kinases in the center of research on Alzheimer's disease (AD), involved in the pathological symptoms of AD, Aβ plaque formation, tau hyperphosphorylation and neurodegeneration. So far, both kinases have mostly been examined in isolation, leading to a schism of the res...
Autores principales: | Engmann, Olivia, Giese, Karl Peter |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2694676/ https://www.ncbi.nlm.nih.gov/pubmed/19521544 http://dx.doi.org/10.3389/neuro.02.002.2009 |
Ejemplares similares
-
Generation of the Cdk5 activator p25 is a memory mechanism that is affected in early Alzheimer’s disease
por: Giese, K. Peter
Publicado: (2014) -
APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice
por: Baltissen, Danny, et al.
Publicado: (2023) -
GSK-3β, a pivotal kinase in Alzheimer disease
por: Llorens-Marítin, María, et al.
Publicado: (2014) -
GSK3β and Tau Protein in Alzheimer’s Disease and Epilepsy
por: Toral-Rios, Danira, et al.
Publicado: (2020) -
Cdk5 and GSK3β inhibit fast endophilin-mediated endocytosis
por: Ferreira, Antonio P. A., et al.
Publicado: (2021)